Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0210815 COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF HEPATIC CANCERS
The present invention relates to methods of treating liver cancer using a Notch signaling inhibitor. Compositions and methods for the treatment of liver...
2017/0210814 METHODS FOR TARGETING PULMONARY DISEASES WITH AGENTS THAT BIND A TARGET IN PULMONARY TISSUE
Disclosed is the use of an agent (e.g., antibody fragment, antagonist, ligand, dAb monomer) that binds a target in pulmonary tissue for the manufacture of a...
2017/0210813 ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF
The present invention provides antibodies that bind to platelet derived growth factor receptor beta (PDGFR-beta) and methods of using the same. According to...
2017/0210812 ANTIBODIES SPECIFIC FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND THEIR USES
The present invention provides antibodies that specifically bind to EGFRvIII (Epidermal Growth Factor Receptor Variant III). The invention further provides...
2017/0210811 Chimeric Antigen Receptors Targeting Epidermal Growth Factor Receptor Variant III
The invention provides Chimeric Antigen Receptors (CARs) that specifically bind to EGFRvIII (Epidermal Growth Factor Receptor Variant III). The invention...
2017/0210810 BIOMARKER PROFILES FOR PREDICTING OUTCOMES OF CANCER THERAPY WITH ERBB3 INHIBITORS AND/OR CHEMOTHERAPIES
Provided are methods for optimizing therapy of, treating a patient having, or selecting (identifying) patients who will benefit from treatment for, a cancer...
2017/0210809 BISPECIFIC BINDING AGENTS TARGETING THE IGF-1R AND ERBB3 PATHWAYS AND USES THEREOF
Disclosed are bispecific binding agents that specifically target both of the IGF-1 and the ErbB intracellular signaling pathways. For example, bispecific...
2017/0210808 ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments,...
2017/0210807 HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR
The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies.
2017/0210806 ANTI-PD-1 ANTIBODY AND USE THEREOF
A PD-1 antibody or a functional fragment thereof, and use of said antibody in the preparation of a medicament for treating tumors are provided.
2017/0210805 ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES
The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB...
2017/0210804 ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
Antibody molecules that specifically bind to LAG-3 are disclosed. The anti-LAG-3 antibody molecules can be used to treat, prevent and/or diagnose cancerous or...
2017/0210803 TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
Methods are provided for targeting cells for depletion, including without limitation cancer cells, in a regimen comprising contacting the targeted cells with a...
2017/0210802 MULTISPECIFIC ANTIGEN BINDING PROTEINS
Multimeric multispecific proteins formed from dimerization between CH1 and CK domains and that bind two target antigens are provided. The proteins have...
2017/0210801 ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES
The present disclosure relates to an isolated anti-FcRn antibody, which is an antibody binding to FcRn (stands for neonatal Fc receptor, also called FcRP, FcRB...
2017/0210800 APLNR Modulators and Uses Thereof
The present invention provides apelin receptor (APLNR) modulators that bind to APLNR and methods of using the same. The invention includes APLNR modulators...
2017/0210799 ANTI-ROR1, ANTIBODIES, ROR1 X CD3 BISPECIFIC ANTIBODIES, AND METHODS OF USING THE SAME
Provided herein are isolated antibodies that immunospecifically bind to ROR1, bispecific antibodies comprising an antigen-binding site that immunospecifically...
2017/0210798 COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION
Provided herein are proteins, antibodies, assays and methods useful for modulating growth factor levels and/or activities. In some embodiments, such growth...
2017/0210797 Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor
The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as...
2017/0210796 Stable Dual Variable Domain Immunoglobulin Protein Formulations
The invention provides stable aqueous formulations comprising an Aqueous Stable Dual Variable Domain Immunoglobulin (AS-DVD-Ig) protein. The invention also...
2017/0210795 USES AND COMPOSITIONS FOR TREATMENT OF PSORIATIC ARTHRITIS
The invention provides methods, uses and compositions for the treatment of psoriatic arthritis. The invention describes methods and uses for treating psoriatic...
2017/0210794 CHARACTERIZATION OF CHO-MIF GENE AND PROTEIN, AND USE THEREOF
The present invention is concerned with the specific and highly sensitive detection of specific CHO-MIF complexes in the production of anti-MIF antibodies. The...
2017/0210793 Novel Treatment for Polycystic Kidney Disease
The invention comprises the administration of dimeric IgA or pentameric IgM antibodies to animals, including human patients, suffering from a disease state...
2017/0210792 ANTIBODY FORMULATIONS
Described herein are anti-sclerostin antibody crystals, methods of making such antibody crystals and formulations comprising the antibody crystals.
2017/0210791 ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU
The invention relates to antibodies, antibody fragments and binding agents that specifically recognize oligomeric tau but do not bind to monomelic tau,...
2017/0210790 HUMAN ANTIBODIES TO FEL D1 AND METHODS OF USE THEREOF
The present invention provides antibodies that bind to the cat allergen, Fel d1, compositions comprising the antibodies, nucleic acids encoding the antibodies...
2017/0210789 SERUM ALBUMIN BINDING PROTEINS
The present invention relates to amino acid sequences that are capable of binding to serum albumin; to proteins and polypeptides comprising or essentially...
2017/0210788 MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modified polynucleotides comprising at least one...
2017/0210787 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT SPECIFICALLY BIND TO MICROTUBULE-ASSOCIATED PROTEIN TAU
The disclosure relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The disclosure also relates to...
2017/0210786 Combination of Broadly Neutralizing HIV Antibodies and Viral Inducers
The present invention relates to methods and agents for preventing the establishment of HIV-1 latent reservoirs or for reducing the size of the reservoirs....
2017/0210785 RAPID METHOD FOR CLONING AND EXPRESSION OF COGNATE ANTIBODY VARIABLE REGION GENE SEGMENTS
In the method as reported herein the isolation of nucleic acid segments encoding antibody variable domains and the insertion of the isolated nucleic acid...
2017/0210784 A NOVEL PROCESS FOR PURIFICATION OF RHU-GCSF
The present invention provides a novel, scalable and industrially viable downstream process for purification of recombinant human G-CSF.
2017/0210783 Composition Containing SMAD Protein For Treatment Of Autoimmune Diseases, A Fusion Protein Comprising SMAD...
The present invention relates to a composition and a fusion protein for prevention or treatment of autoimmune diseases, which contain a Smad protein, and...
2017/0210782 PEPTIDES FOR THE SPECIFIC BINDING OF RNA TARGETS
A recombinant polypeptide is described which comprises at least one PUF RNA-binding domain capable of specifically binding to a cytosine RNA base. The PUF...
2017/0210780 Peptide Fragments of Netrin-1 and Compositions and Methods Thereof
Disclosed herein are peptide fragments derived from netrin-1 and compositions thereof and methods of using thereof. In some embodiments, the present invention...
2017/0210779 N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of...
2017/0210778 NOVEL COMPOUNDS
A compound of formula (I) or a pharmaceutically acceptable derivative thereof, (formula 1) wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, X, m and n are...
2017/0210777 ANTIBODY-BINDING POLYPEPTIDE, ANTIBODY-BINDING FUSION POLYPEPTIDE, AND ADSORPTION MATERIAL
Provided are an antibody-binding polypeptide as set forth in any one of SEQ ID NOS: 1 to 18 and an adsorption material of an antibody or antibody derivative in...
2017/0210776 CATIONIC STEROIDAL ANTIMICROBIALS
Disclosed herein are cationic steroidal antimicrobials ("CSA compounds" or "ceragenins") and methods of making the same. Particularly advantageous methods are...
2017/0210775 GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS
The present invention relates to the methods for preparing synthetic guggulphospholipids, their fatty acid analogues and other bioactive molecules. The present...
2017/0210774 Crystalline Form Of Nicotinamide Riboside
Provided are crystalline forms of nicotinamide riboside, including a Form I of nicotinamide riboside chloride according to formula (I). Also disclosed are...
2017/0210773 Synthesis of Metal Carboxylate Compounds
A method of producing a metal carboxylate compound, comprising (a) combining an organometallic compound with a stoichiometric excess of carboxylic acid; (b)...
2017/0210772 Cleavable Conjugates of Functionalized Platinum-Acridine and Platinum-Benzacridine Agents and Methods Thereof
The present invention relates to using a versatile synthetic approach to generate a new class of ester, amido, or carbamate prodrugs of highly potent, but...
2017/0210771 IRIDIUM PINCER COMPLEX FOR ALKANE DEHYDROGENATION PROCESS
Disclosed herein are processes for dehydrogenation of an alkane to an alkene using an iridium pincer complex and iridium pincer complexes. In the...
2017/0210770 PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS
The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that...
2017/0210769 TH-302 SOLID FORMS AND METHODS RELATED THERETO
The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may...
2017/0210768 Novel Chiral Aziridine Phosphoramidate Compounds
The invention includes processes for the synthesis of amphetamine, dexamphetamine, methamphetamine, derivatives of these, including their salts, and novel...
2017/0210767 LYSOPHOSPHATIDYLSERINE DERIVATIVE
An object of the present invention is to provide a lysophosphatidylserine derivative or a salt thereof. The present invention provides a lysophosphatidylserine...
2017/0210766 SILICON-BASED CROSS COUPLING AGENTS AND METHODS OF THEIR USE
Compositions and methods using silicon-based cross-coupling agents in the formation of carbon-carbon and carbon-nitrogen bonds are described.
2017/0210765 PROCESS FOR PREPARING ALPHA-SILYLAMINE COMPOUNDS FROM ALPHA-SILYLMETHYL AZIDE COMPOUNDS
The present invention relates to a process for preparing alpha-silylamine compounds and, more specifically, to a one-pot process for preparing various...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.